{"id":"levonorgestrel-ius","safety":{"commonSideEffects":[{"rate":"20-30","effect":"Irregular bleeding or amenorrhea"},{"rate":"5-10","effect":"Headache"},{"rate":"5-10","effect":"Breast tenderness"},{"rate":"5-15","effect":"Pelvic pain or cramping"},{"rate":"5","effect":"Acne"},{"rate":"2-5","effect":"Mood changes"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The levonorgestrel IUS delivers a continuous low dose of the progestin levonorgestrel locally within the uterine cavity over several years. This creates a hostile environment for sperm penetration by thickening cervical mucus, suppresses endometrial proliferation to prevent implantation, and partially inhibits ovulation. The local delivery minimizes systemic hormone exposure compared to oral contraceptives.","oneSentence":"Levonorgestrel IUS is an intrauterine system that releases the synthetic progestin levonorgestrel directly into the uterus to prevent pregnancy through multiple mechanisms including cervical mucus thickening, endometrial suppression, and ovulation inhibition.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:34:01.431Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Contraception"},{"name":"Heavy menstrual bleeding (off-label/secondary indication)"}]},"trialDetails":[{"nctId":"NCT05172999","phase":"PHASE2, PHASE3","title":"Loxenatide Plus LNG-IUS in Endometrial Atypical Hyperplasia","status":"COMPLETED","sponsor":"Fudan University","startDate":"2022-01-08","conditions":"Atypical Endometrial Hyperplasia, Obesity, Fertility Issues","enrollment":30},{"nctId":"NCT05316493","phase":"PHASE2, PHASE3","title":"Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia","status":"RECRUITING","sponsor":"Xiaojun Chen","startDate":"2022-06-13","conditions":"Atypical Endometrial Hyperplasia, Fertility Issues, Overweight and Obesity","enrollment":172},{"nctId":"NCT01088178","phase":"NA","title":"Levonorgestrel-Intrauterine System (LNG-IUS) Insertion in the Postpartum Period","status":"WITHDRAWN","sponsor":"United States Naval Medical Center, Portsmouth","startDate":"2009-11","conditions":"Contraception","enrollment":""},{"nctId":"NCT01161095","phase":"NA","title":"A Multicenter Analysis of Levonorgestrel-Intrauterine System (LNG-IUS) Use in the Postpartum Period","status":"WITHDRAWN","sponsor":"United States Naval Medical Center, Portsmouth","startDate":"2010-07-01","conditions":"Contraception, Postpartum Period","enrollment":""},{"nctId":"NCT05233956","phase":"NA","title":"Levonorgestrel Intrauterine System Effects on Hemoglobin and Serum Ferritin Among Anemic Women in Kenya","status":"RECRUITING","sponsor":"FHI 360","startDate":"2023-10-23","conditions":"Anemia","enrollment":600},{"nctId":"NCT02146950","phase":"","title":"European Active Surveillance Study of LCS12","status":"ACTIVE_NOT_RECRUITING","sponsor":"Center for Epidemiology and Health Research, Germany","startDate":"2014-06-17","conditions":"Contraception","enrollment":97265},{"nctId":"NCT03751800","phase":"","title":"A Study Run At Multiple Study Sites to Test Whether the SAMANTA Questionnaire That is Used to Diagnose Heavy Menstrual Bleeding (HMB), Can Also Be Used to Assess Changes of Severity of HMB in Women with HMB Who Are Treated During 12 Months with a Chronic Hormonal Treatment","status":"COMPLETED","sponsor":"Bayer","startDate":"2018-12-12","conditions":"Menorrhagia","enrollment":422},{"nctId":"NCT06620939","phase":"NA","title":"The Effect of Levonorgestrel Intrauterine System in Preventing Endometrial Polyps Recurrence","status":"NOT_YET_RECRUITING","sponsor":"Zhang Jian","startDate":"2024-12-01","conditions":"Endometrial Polyp","enrollment":558},{"nctId":"NCT03241888","phase":"PHASE2, PHASE3","title":"Megestrol Acetate Plus LNG-IUS in Young Women With Endometrial Atypical Hyperplasia","status":"COMPLETED","sponsor":"Fudan University","startDate":"2017-07-04","conditions":"Atypical Endometrial Hyperplasia","enrollment":180},{"nctId":"NCT06468215","phase":"NA","title":"Fertility Sparing Therapy for Patients With Stage IA G2 Endometrial Cancer","status":"NOT_YET_RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2024-07","conditions":"Carcinoma, Endometrioid, Fertility Preservation","enrollment":16},{"nctId":"NCT01539720","phase":"NA","title":"Levonorgestrel Intrauterine System For Emergency Contraception","status":"COMPLETED","sponsor":"Planned Parenthood of the St. Louis Region and Southwest Missouri","startDate":"2012-12","conditions":"Pregnancy, Unplanned, Pregnancy; Accident","enrollment":274},{"nctId":"NCT01721798","phase":"NA","title":"Comparison of Two Intrauterine Devices (IUDs) Among Cape Town HIV-positive Women","status":"COMPLETED","sponsor":"FHI 360","startDate":"2013-11-10","conditions":"HIV","enrollment":199},{"nctId":"NCT03493295","phase":"","title":"Non-interventional, Real Life Study on Satisfaction With LNG-IUS in Spanish Young Women (18-30 Years Old) With Different Parity Status and Menstrual Bleeding Pattern","status":"COMPLETED","sponsor":"Bayer","startDate":"2018-04-25","conditions":"Contraception","enrollment":587},{"nctId":"NCT04814927","phase":"PHASE4","title":"Impact of Contraceptives on Cervico-Vaginal Mucosa","status":"COMPLETED","sponsor":"Eastern Virginia Medical School","startDate":"2021-03-01","conditions":"Mucosal Inflammation, Contraceptive; Complications, Intrauterine","enrollment":112},{"nctId":"NCT05986344","phase":"","title":"Uterine Artery Doppler and Menstrual Changes After Insertion Intrauterine Contraceptive Device","status":"UNKNOWN","sponsor":"Beni-Suef University","startDate":"2023-08-30","conditions":"Intrauterine Contraceptive Device Complication","enrollment":165},{"nctId":"NCT04897217","phase":"PHASE3","title":"Levonorgestrel-Releasing Intrauterine System (LNG-IUS) in the Management of Atypical Endometrial Hyperplasia","status":"WITHDRAWN","sponsor":"Wake Forest University Health Sciences","startDate":"2023-06-30","conditions":"Endometrial Hyperplasia","enrollment":""},{"nctId":"NCT03074045","phase":"PHASE3","title":"LCS16 vs. COC User Satisfaction and Tolerability Study","status":"COMPLETED","sponsor":"Bayer","startDate":"2017-03-13","conditions":"Contraception","enrollment":145},{"nctId":"NCT04785950","phase":"","title":"The Aim of This Study is to Estimate the Discontinuation Rate of Low-dose Levonorgestrel-releasing Intrauterine System Due to Self-reported Unacceptable Menstrual Bleeding Pattern in Spanish Women Who Are Using it for the First Time How Intrauterine System for Long Acting Contraception","status":"COMPLETED","sponsor":"Bayer","startDate":"2021-02-21","conditions":"Hormonal Intrauterine Contraception","enrollment":316},{"nctId":"NCT00635362","phase":"NA","title":"Postplacental Insertion of Levonorgestrel-releasing Intrauterine System (LNG-IUS) After Cesarean vs. Interval Insertion","status":"TERMINATED","sponsor":"University of Chicago","startDate":"2007-05","conditions":"Healthy","enrollment":42},{"nctId":"NCT00653159","phase":"PHASE4","title":"Maintaining Intrauterine Devices (IUDs) in Teens (MINT): A Randomization Trial","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2007-07","conditions":"Contraception","enrollment":23},{"nctId":"NCT04385667","phase":"PHASE2, PHASE3","title":"LVN- IUS Versus Oral Megesterol Acetate in Treatment of Atypical Endometrial Hyperplasia","status":"COMPLETED","sponsor":"Zagazig University","startDate":"2020-05-20","conditions":"Atypical Endometrial Hyperplasia","enrollment":143},{"nctId":"NCT05565573","phase":"PHASE2, PHASE3","title":"Medroxyprogesterone Acetate vs LNG-IUS in Early-stage Endometrioid Carcinoma and Atypical Hyperplasia Patients","status":"UNKNOWN","sponsor":"Hua Li","startDate":"2022-11-01","conditions":"Fertility Sparing","enrollment":148},{"nctId":"NCT05492487","phase":"PHASE2","title":"A Pilot Study on Fertility Conservative Treatment of Atypical Endometrial Hyperplasia in Singapore","status":"UNKNOWN","sponsor":"KK Women's and Children's Hospital","startDate":"2020-01-03","conditions":"Endometrial Hyperplasia, Fertility Issues, Disease Regression","enrollment":60},{"nctId":"NCT02985541","phase":"PHASE3","title":"Mirena Extension Trial","status":"COMPLETED","sponsor":"Bayer","startDate":"2016-12-22","conditions":"Contraception","enrollment":364},{"nctId":"NCT05343546","phase":"NA","title":"Ideal Timing of Intrauterine Contraception Insertion After Medical Management of First Trimester Incomplete Abortion","status":"UNKNOWN","sponsor":"Makerere University","startDate":"2022-06","conditions":"Incomplete Abortion, Intrauterine Contraception, Misoprostol","enrollment":2076},{"nctId":"NCT05152667","phase":"","title":"Ambispective Study to Assess the Effect of Pretreatment With a Levonorgestrel-Releasing Intrauterine System Versus Oral Progestin","status":"UNKNOWN","sponsor":"Wael Elbanna Clinic","startDate":"2021-11-27","conditions":"Adenomyosis, IVF","enrollment":354},{"nctId":"NCT03317795","phase":"PHASE4","title":"Treatment of Heavy Menstrual Bleeding in Women With Uterine Fibroids","status":"COMPLETED","sponsor":"Shannon K. Laughlin-Tommaso","startDate":"2017-11-14","conditions":"Heavy Menstrual Bleeding, Menorrhagia, Uterine Fibroids","enrollment":18},{"nctId":"NCT03463252","phase":"PHASE2, PHASE3","title":"Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC","status":"RECRUITING","sponsor":"West China Second University Hospital","startDate":"2018-04-01","conditions":"Endometrial Cancer, Atypical Endometrial Hyperplasia","enrollment":224},{"nctId":"NCT03182140","phase":"","title":"KYleena Satisfaction Study / Observational Study on User Satisfaction With the Levonorgestrel Intrauterine Delivery System Kyleena (LNG-IUS 12) in New Contraceptive Users and After Switching From Another Contraceptive Method","status":"COMPLETED","sponsor":"Bayer","startDate":"2017-07-06","conditions":"Contraception","enrollment":1134},{"nctId":"NCT02556411","phase":"NA","title":"Comparison of Estrogen-progestin Therapy in Continuous Regimen Versus Combination Estrogen-progestin Therapy in Continuous Regimen Plus Levonorgestrel-releasing Intrauterine System (LNG-IUS)","status":"UNKNOWN","sponsor":"University of Cagliari","startDate":"2021-06-01","conditions":"Adenomyosis, Chronic Pelvic Pain","enrollment":50},{"nctId":"NCT03428854","phase":"","title":"Adenomyosis: Genomic Mechanisms and Biological Response","status":"WITHDRAWN","sponsor":"University of Texas Southwestern Medical Center","startDate":"2020-12-01","conditions":"Adenomyosis, Abnormal Uterine Bleeding","enrollment":""},{"nctId":"NCT02475356","phase":"","title":"Prospective, Non-interventional, Multi-center Safety Study of Mirena for Heavy Menstrual Bleeding and Dysmenorrhea","status":"COMPLETED","sponsor":"Bayer","startDate":"2015-08-04","conditions":"Menorrhagia, Dysmenorrhea","enrollment":601},{"nctId":"NCT03992937","phase":"NA","title":"Vaginal Micronized Progesterone Versus Levonorgestrel for Treatment of Non-atypical Endometrial Hyperplasia","status":"COMPLETED","sponsor":"Kocaeli University","startDate":"2019-06-20","conditions":"Endometrial Hyperplasia Without Atypia","enrollment":132},{"nctId":"NCT03241914","phase":"PHASE2, PHASE3","title":"Megestrol Acetate Plus LNG-IUS in Young Women With Early Endometrial Cancer","status":"COMPLETED","sponsor":"Fudan University","startDate":"2017-07-04","conditions":"Endometrial Neoplasm Malignant Stage I","enrollment":64},{"nctId":"NCT01805817","phase":"PHASE4","title":"Comparison of Levonorgestrel Intrauterine System, Copper T Intrauterine Device and Oral Contraceptives on Life Quality","status":"WITHDRAWN","sponsor":"Istanbul Training and Research Hospital","startDate":"2012-12","conditions":"Contraceptive Methods Comparison","enrollment":""},{"nctId":"NCT03562624","phase":"PHASE2","title":"A Study to Compare 3 Doses of a Hormonal Intra-uterine Device Containing Levonorgestrel and Indomethacin With a Hormonal Intra-uterine Device Containing Only Levonorgestrel to Assess the Effect and Safety of the Combined Components","status":"COMPLETED","sponsor":"Bayer","startDate":"2018-06-22","conditions":"Contraception","enrollment":177},{"nctId":"NCT03111342","phase":"PHASE4","title":"Intracervical Anesthesia and Pain Associated With Intrauterine Contraceptive Insertion","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2017-06-01","conditions":"Pain, Acute, Anesthesia, Local, IUD Insertion Complication","enrollment":300},{"nctId":"NCT02067663","phase":"","title":"Comparison of the Levonorgestrel IUD and the Copper IUD Placed in the Immediate Postplacental Period: A Prospective Cohort Study","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2014-04","conditions":"Contraception","enrollment":123},{"nctId":"NCT02824224","phase":"PHASE4","title":"Tamoxifen to Reduce Unscheduled Bleeding in New Users of the Levonorgestrel-releasing Intrauterine System (LNG-IUS)","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2016-09-06","conditions":"Menorrhagia, Metrorrhagia, Medicated Intrauterine Devices","enrollment":42},{"nctId":"NCT01594476","phase":"PHASE4","title":"Early Postpartum Intrauterine Device (IUD) Placement","status":"TERMINATED","sponsor":"Oregon Health and Science University","startDate":"2012-03","conditions":"Contraception","enrollment":201},{"nctId":"NCT03230994","phase":"","title":"Cooperative Adenomyosis Network","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2017-06-30","conditions":"Dysmenorrhea, Metrorrhagia, Infertility, Female","enrollment":5000},{"nctId":"NCT02456584","phase":"PHASE1","title":"Pharmacodynamics and Pharmacokinetics Study of Existing DMPA Contraceptive Methods","status":"COMPLETED","sponsor":"FHI 360","startDate":"2015-09","conditions":"Contraception","enrollment":42},{"nctId":"NCT01299116","phase":"PHASE4","title":"Long-Acting Reversible Contraception","status":"COMPLETED","sponsor":"FHI 360","startDate":"2011-12","conditions":"Contraception","enrollment":916},{"nctId":"NCT01240811","phase":"NA","title":"Study of Immune Cell Changes in the Genital Tract 2 Months After Initiation of an IUD for Contraception","status":"COMPLETED","sponsor":"Sharon Achilles","startDate":"2010-11","conditions":"Genital Tract Mucosal Immunity, Genital Tract Microflora","enrollment":42},{"nctId":"NCT01601366","phase":"PHASE2","title":"LNG-IUS for Treatment of Dysmenorrhea","status":"COMPLETED","sponsor":"Omar Mamdouh Shaaban","startDate":"2012-04","conditions":"Adenomyosis","enrollment":62},{"nctId":"NCT01254292","phase":"PHASE3","title":"LCS12 vs Combined Oral Contraceptive (COC) User Satisfaction Study","status":"COMPLETED","sponsor":"Bayer","startDate":"2011-01-06","conditions":"Contraception","enrollment":567},{"nctId":"NCT01594632","phase":"NA","title":"Safety,Effectiveness and Acceptability of Sino-implant II in DR","status":"COMPLETED","sponsor":"FHI 360","startDate":"2011-01","conditions":"Contraception","enrollment":650},{"nctId":"NCT02121067","phase":"PHASE4","title":"LNG-IUS at 2 Weeks Postpartum","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2014-09","conditions":"Contraception, Malposition of Intrauterine Contraceptive Device","enrollment":50},{"nctId":"NCT00997932","phase":"PHASE4","title":"A Pilot Study of Early Postpartum Intrauterine Contraception","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2009-06","conditions":"Unplanned Pregnancy","enrollment":40},{"nctId":"NCT02534688","phase":"PHASE4","title":"Effectiveness of Levonorgestrel-intrauterine System (LNG-IUS) Versus Depot Medroxyprogesterone Acetate (DMPA) in Treatment of Pelvic Pain in Clinically Diagnosed Endometriotic Patients","status":"COMPLETED","sponsor":"King Chulalongkorn Memorial Hospital","startDate":"2015-06","conditions":"Endometriosis","enrollment":50},{"nctId":"NCT02414919","phase":"","title":"Duration of Use of Highly Effective Reversible Contraception","status":"COMPLETED","sponsor":"Bayer","startDate":"2015-04-01","conditions":"Pregnancy","enrollment":13880},{"nctId":"NCT00528112","phase":"PHASE3","title":"Levonorgestrel Contraceptive Intrauterine Systems (LCS) Pearl Index Study","status":"COMPLETED","sponsor":"Bayer","startDate":"2007-08","conditions":"Contraception","enrollment":2885},{"nctId":"NCT03027648","phase":"NA","title":"Levonorgestrel-releasing Intrauterine System for the Treatment of Symptomatic Adenomyosis","status":"COMPLETED","sponsor":"Peking Union Medical College Hospital","startDate":"2006-12","conditions":"Adenomyosis","enrollment":1100},{"nctId":"NCT02990728","phase":"PHASE2","title":"Mirena® ± Metformin as Fertility-preserving Treatment for Young Asian Women With Early Endometrial Cancer","status":"UNKNOWN","sponsor":"Chang Gung Memorial Hospital","startDate":"2016-03","conditions":"Endometrial Cancer","enrollment":120},{"nctId":"NCT02894151","phase":"PHASE2","title":"Effectiveness of Levonorgestrel-intrauterine System (LNG-IUS) Versus Depot Medroxyprogesterone Acetate (DMPA) in Treatment of Pelvic Pain in Clinically Diagnosed Endometriotic Patients","status":"COMPLETED","sponsor":"Chulalongkorn University","startDate":"2015-04","conditions":"Clinically Diagnosed Endometriotic Patient Was Defined as a Woman Who Has Pelvic Pain and at Least One Evidence of PV or TVS","enrollment":50},{"nctId":"NCT01931657","phase":"PHASE2","title":"Pretreatment With Mifepristone Prior to Mirena Insertion","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"2013-08","conditions":"Women in Need of Long Acting Reversibel Cntraception With the Intrauterine Levonorgestrel Releasing System, Mirena","enrollment":60},{"nctId":"NCT02362373","phase":"PHASE4","title":"Women With Epilepsy: a Pilot Study of PK and PD Anti-epileptic Drug Effects in Levonorgestrel Intrauterine System Users","status":"COMPLETED","sponsor":"Columbia University","startDate":"2011-08","conditions":"Epilepsy, Contraception","enrollment":20},{"nctId":"NCT01958684","phase":"","title":"Bleeding Pattern Difference Between Levonorgestrel Intrauterine System (LNG-IUS) and Copper Intrauterine Devices (IUDs) Immediately Inserted After Abortion","status":"COMPLETED","sponsor":"Bayer","startDate":"2013-10","conditions":"Contraception","enrollment":512},{"nctId":"NCT00185380","phase":"PHASE2","title":"Dose-finding Study for the Ultralow-dose Levonorgestrel Intrauterine Contraceptive System (LCS)","status":"COMPLETED","sponsor":"Bayer","startDate":"2005-04","conditions":"Contraception","enrollment":742},{"nctId":"NCT02461862","phase":"","title":"Vital Signs and Pain During Insertion of IUD","status":"COMPLETED","sponsor":"Federal University of São Paulo","startDate":"2015-01","conditions":"Contraception, Acute Pain","enrollment":285},{"nctId":"NCT01595022","phase":"PHASE1","title":"FR01 and FR20 IUS (Intrauterine System) Wearing Study","status":"COMPLETED","sponsor":"Bayer","startDate":"2010-01","conditions":"Contraception","enrollment":90},{"nctId":"NCT00868153","phase":"","title":"Mirena in Idiopathic Menorrhagia","status":"COMPLETED","sponsor":"Bayer","startDate":"2004-08","conditions":"Idiopathic Menorrhagia","enrollment":1125},{"nctId":"NCT02155166","phase":"NA","title":"Effect of Intracervical on the Pain Associated With the Insertion of the LNG-IUS","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2012-02","conditions":"Pain","enrollment":100},{"nctId":"NCT02158845","phase":"PHASE4","title":"Levonorgestrel-releasing Intrauterine System in Patients With Endometriosis","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2010-02","conditions":"Endometriosis","enrollment":44},{"nctId":"NCT01295294","phase":"PHASE4","title":"Management of Initial Bleeding/Spotting Associated With the Levonorgestrel-releasing Intrauterine System (MIRENA)","status":"COMPLETED","sponsor":"Bayer","startDate":"2011-03","conditions":"Uterine Hemorrhage","enrollment":187},{"nctId":"NCT01943058","phase":"PHASE2","title":"Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer","status":"WITHDRAWN","sponsor":"University of Southern California","startDate":"2014-03","conditions":"Atypical Endometrial Hyperplasia, Endometrial Adenocarcinoma, Recurrent Endometrial Carcinoma","enrollment":""},{"nctId":"NCT00884260","phase":"PHASE3","title":"GA Levonorgestrel Intrauterine Contraceptive System (LCS) Phase III Study China","status":"COMPLETED","sponsor":"Bayer","startDate":"2009-04","conditions":"Contraception","enrollment":918},{"nctId":"NCT01414140","phase":"","title":"Mirena Post-marketing Surveillance in Japan","status":"COMPLETED","sponsor":"Bayer","startDate":"2007-05","conditions":"Contraception","enrollment":567},{"nctId":"NCT00931827","phase":"","title":"Acceptability of Long-term Progestin-only Contraception in Europe","status":"COMPLETED","sponsor":"Bayer","startDate":"2008-01","conditions":"Contraception","enrollment":436},{"nctId":"NCT00360490","phase":"PHASE3","title":"Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS)","status":"COMPLETED","sponsor":"Bayer","startDate":"2006-07","conditions":"Menorrhagia","enrollment":165},{"nctId":"NCT01392157","phase":"PHASE4","title":"Acceptability and Continuation Rate of Implanon in a Brazilian Public Sector","status":"COMPLETED","sponsor":"University of Campinas, Brazil","startDate":"2011-06","conditions":"Contraceptive Usage, Bleeding Due to Intrauterine Contraceptive Device","enrollment":300},{"nctId":"NCT00185458","phase":"PHASE3","title":"Assessment of the Transfer of Using Levonorgestrel Intrauterine System (LNG IUS) as a Contraceptive to Using it as Part of Hormone Replacement Therapy (HRT).","status":"COMPLETED","sponsor":"Bayer","startDate":"2000-05","conditions":"Menopause","enrollment":394},{"nctId":"NCT01965587","phase":"NA","title":"RCT Novasure Versus Novasure + Mirena IUS in the Treatment of Menorrhagia","status":"UNKNOWN","sponsor":"Walsall Healthcare NHS Trust","startDate":"2013-12","conditions":"Menorrhagia","enrollment":100},{"nctId":"NCT01234818","phase":"PHASE2","title":"Management of Endometrial Hyperplasia With a LNG-IUS: Multicenter Study: KGOG2006","status":"UNKNOWN","sponsor":"Korean Gynecologic Oncology Group","startDate":"2010-11","conditions":"Endometrial Hyperplasia","enrollment":80},{"nctId":"NCT01695902","phase":"PHASE3","title":"Therapeutic Equivalence Trial of Two Hormonal-IUDs in Patients With Heavy Menstrual Bleeding","status":"COMPLETED","sponsor":"Uteron Pharma S.A.","startDate":"2007-12","conditions":"Heavy Menstrual Bleeding","enrollment":280},{"nctId":"NCT01388582","phase":"PHASE4","title":"The Effect of Hormonal Contraceptives on Breast-milk Production and Infant Growth","status":"COMPLETED","sponsor":"University of Campinas, Brazil","startDate":"2011-04","conditions":"Underweight","enrollment":40},{"nctId":"NCT01594879","phase":"PHASE2","title":"Treatment With Medroxyprogesterone Acetate Plus LNG-IUS in Young Women With Early Stage Endometrial Cancer","status":"UNKNOWN","sponsor":"Korean Gynecologic Oncology Group","startDate":"2012-01","conditions":"Endometrial Cancer","enrollment":39},{"nctId":"NCT01499602","phase":"NA","title":"Efficacy of LNG-IUS for Treatment of Non-atypical Endometrial Hyperplasia in Perimenopausal Women","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2009-05","conditions":"Endometrial Hyperplasia","enrollment":120},{"nctId":"NCT00570440","phase":"PHASE4","title":"Continuous Use of COCs","status":"COMPLETED","sponsor":"FHI 360","startDate":"2007-08","conditions":"Pregnancy Prevention","enrollment":362},{"nctId":"NCT00621543","phase":"NA","title":"Insertion of an Intrauterine Device (IUD) After Medical Abortion","status":"COMPLETED","sponsor":"Boston University","startDate":"2006-03","conditions":"Intrauterine Device Expulsion, Medical Abortion, Induced Abortion","enrollment":120},{"nctId":"NCT01391052","phase":"PHASE4","title":"Pretreatment With Norethindrone Acetate Prior to Levonorgestrel IUS Insertion for Heavy Menstrual Bleeding","status":"UNKNOWN","sponsor":"Scott and White Hospital & Clinic","startDate":"2011-01","conditions":"Heavy Menstrual Bleeding, Menorrhagia, Hypermenorrhea","enrollment":80},{"nctId":"NCT01320917","phase":"PHASE4","title":"Levonorgestrel-releasing Intrauterine Device on Obese Women: Effects on Hemostatic and Arterial Function","status":"UNKNOWN","sponsor":"University of Sao Paulo","startDate":"2009-02","conditions":"Contraception Desired, Obesity","enrollment":88},{"nctId":"NCT01125488","phase":"PHASE3","title":"Maintenance Therapy of Levonorgestrel-releasing Intrauterine System (LNG-IUS) to Prevent the Recurrence of Symptomatic Endometriosis After Conservative Surgery","status":"UNKNOWN","sponsor":"Taipei Veterans General Hospital, Taiwan","startDate":"2008-03","conditions":"Endometriosis","enrollment":80},{"nctId":"NCT00966264","phase":"PHASE3","title":"Hysterectomy and Levonorgestrel Releasing Intrauterine System (LNG-IUS) in the Treatment of Menorrhagia","status":"COMPLETED","sponsor":"University of Helsinki","startDate":"1994-10","conditions":"Menorrhagia","enrollment":236},{"nctId":"NCT00489463","phase":"NA","title":"IUD Uterine Vascularization and Side Effects","status":"COMPLETED","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2004-01","conditions":"Healthy","enrollment":63}],"_emaApprovals":[],"_faersSignals":[{"count":25,"reaction":"DRUG INEFFECTIVE"},{"count":20,"reaction":"PREGNANCY WITH CONTRACEPTIVE DEVICE"},{"count":12,"reaction":"DEVICE DISLOCATION"},{"count":12,"reaction":"DEVICE EXPULSION"},{"count":12,"reaction":"EMBEDDED DEVICE"},{"count":10,"reaction":"GENITAL HAEMORRHAGE"},{"count":9,"reaction":"DEVICE USE ISSUE"},{"count":9,"reaction":"PROCEDURAL PAIN"},{"count":8,"reaction":"ABDOMINAL PAIN"},{"count":8,"reaction":"MEDICAL DEVICE PAIN"}],"_approvalHistory":[],"publicationCount":37,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Mirena IUS","Paragard IUD","Mirena","Liletta"],"phase":"marketed","status":"active","brandName":"Levonorgestrel IUS","genericName":"Levonorgestrel IUS","companyName":"Oregon Health and Science University","companyId":"oregon-health-and-science-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Levonorgestrel IUS is an intrauterine system that releases the synthetic progestin levonorgestrel directly into the uterus to prevent pregnancy through multiple mechanisms including cervical mucus thickening, endometrial suppression, and ovulation inhibition. Used for Contraception, Heavy menstrual bleeding (off-label/secondary indication).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":2,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}